Email this article to a friend
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
-
* Corresponding author: Filip De Keyser Filip.DeKeyser@Ugent.be
- † Equal contributors
Arthritis Research & Therapy 2005, 7:R1063-R1071 doi:10.1186/ar1787